ATI - Advanced Medical Technologies

Company Overview

Snapshot

Founded in March 2005 by Tomas Mendelsohn, Abraham Livne, and Ilan Ron, ATI - Advanced Medical Technologies operates with 1–10 employees. The company is focused on developing medical devices for the ophthalmology market, with its flagship product, Field-Induced Mydriasis (FIM), being a CE-approved pupil-dilation device.

Business overview

ATI - Advanced Medical Technologies develops innovative medical devices for the ophthalmology market, aiming to enhance patient experience during diagnostic procedures and improve efficiency. Its core product, Field-Induced Mydriasis (FIM), is a non-contact, drug-free device designed for rapid pupil dilation and quick recovery. The company is also developing NIT, a personal ocular tonometer for early glaucoma detection, serving clinics, healthcare providers, and patients in the diagnostics, monitoring, and home-care segments within the Health Tech & Life Sciences sector, particularly in Medical Devices.

Company Intelligence Q&A

What is ATI - Advanced Medical Technologies' primary focus?

ATI - Advanced Medical Technologies specializes in developing medical devices for the ophthalmology market, focusing on improving diagnostic procedures and patient experience.

What is the company's flagship product?

The company's flagship product is Field-Induced Mydriasis (FIM), a CE-approved, non-contact, drug-free device for rapid pupil dilation.

What new product is ATI - Advanced Medical Technologies developing?

ATI - Advanced Medical Technologies is currently developing NIT, a personal ocular tonometer designed for patients to measure their intraocular pressure for the early detection of glaucoma.

What are the key benefits of the FIM device?

The FIM device significantly improves the examination experience by achieving full pupil dilation within 90 to 120 seconds, with full recovery within minutes, and is safe, non-contact, and drug-free.

Which markets does ATI - Advanced Medical Technologies target?

ATI - Advanced Medical Technologies targets the ophthalmology market, with a specific focus on geomarkets such as China, serving clinics, healthcare providers, and patients.